Clinical trial
RxIALTA: Pharmacist CVD Intervention for Patients With Inflammatory Arthritis
NCT03152396 is registered in ClinicalTrials.gov with Epidemiology Coordinating and Research Centre, Canada as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- RxIALTA: Pharmacist CVD Intervention for Patients With Inflammatory Arthritis
- Lead sponsor
- Epidemiology Coordinating and Research Centre, Canada
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- July 17, 2017
- Completion date
- September 30, 2018
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ankylosing spondylitis, cardiovascular risk factor, inflammatory arthritis, psoriatic arthritis, rheumatoid arthritis